BRIZZI, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 734
EU - Europa 705
AS - Asia 124
OC - Oceania 2
SA - Sud America 2
Totale 1.567
Nazione #
US - Stati Uniti d'America 734
GB - Regno Unito 253
IE - Irlanda 146
CN - Cina 114
UA - Ucraina 76
SE - Svezia 68
DE - Germania 52
FR - Francia 39
IT - Italia 38
FI - Finlandia 20
TR - Turchia 6
RU - Federazione Russa 3
SK - Slovacchia (Repubblica Slovacca) 3
VN - Vietnam 3
BE - Belgio 2
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
IM - Isola di Man 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PE - Perù 1
Totale 1.567
Città #
Southend 241
Dublin 146
Fairfield 108
Chandler 82
Jacksonville 63
Menlo Park 53
Wilmington 50
Ashburn 44
Beijing 41
Ann Arbor 37
Seattle 33
Cambridge 29
Houston 28
Woodbridge 27
Nanjing 26
Princeton 25
Siena 20
Fremont 12
Nanchang 10
Dearborn 8
Tianjin 8
Boardman 7
Helsinki 7
San Diego 7
San Mateo 7
Shenyang 7
Izmir 6
Düsseldorf 5
Norwalk 4
Dong Ket 3
Hebei 3
Kunming 3
Milan 3
Shanghai 3
Brussels 2
Guangzhou 2
London 2
Mestre 2
New York 2
Ningbo 2
Redwood City 2
Southwark 2
Anguillara Sabazia 1
Auburn Hills 1
Auckland 1
Bethesda 1
Bonndorf 1
Boston 1
Cava Dei Tirreni 1
Changchun 1
Chongqing 1
Fairlawn 1
Fort Wayne 1
Frankfurt am Main 1
Hangzhou 1
Indiana 1
Jiaxing 1
Lima 1
Melbourne 1
Moscow 1
Málaga 1
Philadelphia 1
Prague 1
Rome 1
San Francisco 1
Sofia 1
Stockholm 1
Tampa 1
Trebaseleghe 1
Tucson 1
Washington 1
Wuhan 1
Xian 1
Zhengzhou 1
Totale 1.204
Nome #
Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors 185
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 158
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo 136
Nuovi Potenti e Selettivi ligandi dei recettori dei cannabinoidi 136
Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol 132
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors 123
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol (2-AG) Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 (CB1) Receptor 122
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist 122
Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoids Receptors 108
In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands 96
Identification and Quantification of Trans-Resveratrol in Dietary Supplements by a Rapid and Straightforward RP-HPLC Method 92
Conformational Analysis of the N-Arachinylethanolamide (Anandamide) using Nuclear Magnetic Resonance and Theoretical Calculations 87
Synthesis, binding affinity and selectivity of new beta1 and beta2 adrenoceptor blockers 72
Totale 1.569
Categoria #
all - tutte 4.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201976 0 0 0 0 0 0 0 0 0 0 39 37
2019/2020308 43 9 19 52 16 27 26 36 18 36 11 15
2020/2021202 9 20 4 21 4 36 6 30 27 10 20 15
2021/2022153 10 31 8 10 4 2 10 9 4 12 15 38
2022/2023275 14 18 48 37 31 53 3 25 28 4 10 4
2023/2024169 5 2 18 7 3 48 81 3 2 0 0 0
Totale 1.569